CYTK — Cytokinetics Cashflow Statement
0.000.00%
Last trade - 00:00
- $6.57bn
- $6.17bn
- $7.53m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -122 | -127 | -215 | -389 | -526 |
Depreciation | |||||
Non-Cash Items | 33.4 | 46.5 | 62.1 | 108 | 96.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.89 | 87.9 | 8.46 | -24.7 | 3.09 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -90.9 | 8.94 | -143 | -300 | -414 |
Capital Expenditures | -2.62 | -11.1 | -48.9 | -11.3 | -1.42 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -72.1 | -185 | -98.9 | -251 | 241 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -74.7 | -197 | -148 | -262 | 239 |
Financing Cash Flow Items | -13.4 | 2.15 | 0 | 14.4 | -10.5 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 160 | 234 | 320 | 516 | 221 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -5.82 | 46.6 | 29.7 | -45.5 | 46.2 |